Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Strata Critical Medical (SRTA) Revenue (2020 - 2025)

Strata Critical Medical (SRTA) has disclosed Revenue for 6 consecutive years, with $66.8 million as the latest value for Q4 2025.

  • Quarterly Revenue rose 83.54% to $66.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $241.2 million through Dec 2025, up 25.68% year-over-year, with the annual reading at $197.1 million for FY2025, 34.28% up from the prior year.
  • Revenue for Q4 2025 was $66.8 million at Strata Critical Medical, up from $49.3 million in the prior quarter.
  • The five-year high for Revenue was $71.4 million in Q3 2023, with the low at $9.3 million in Q1 2021.
  • Average Revenue over 5 years is $43.6 million, with a median of $45.5 million recorded in 2022.
  • The sharpest move saw Revenue surged 276.7% in 2021, then plummeted 49.52% in 2024.
  • Over 5 years, Revenue stood at $24.6 million in 2021, then soared by 54.91% to $38.1 million in 2022, then rose by 24.5% to $47.5 million in 2023, then decreased by 23.36% to $36.4 million in 2024, then surged by 83.54% to $66.8 million in 2025.
  • According to Business Quant data, Revenue over the past three periods came in at $66.8 million, $49.3 million, and $70.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.